← Back to all trials
Completed
NCT07839910
Wearable tDCS and Acute Golf Shot Performance
Conditions: tDCS, Golf Specific Performance, Athletic Performance Enhancement, Healthy Volunteer
Sex: All
Ages: 16 Years – N/A
Healthy volunteers: Yes
Phase: NA
Enrollment: 67
Sponsor: Shanghai University of Sport
Location: Shanghai University of Sport, School of Physical Education Shanghai Shanghai Municipality
Summary
Transcranial direct current stimulation (tDCS) has been investigated as an ergogenic aid for two decades, but most sport evidence comes from laboratory stimulators operated by experimenters. This trial evaluates whether a single 20-minute session of wearable, app-controlled bilateral motor-cortex tDCS (Halo Sport 2, 2 mA) improves full-swing golf shot performance compared with sham stimulation. The study is a double-blind, sham-controlled, parallel-group randomized trial with a pre-test/post-test design in golfers stratified into professional, amateur-high, and amateur-middle skill groups. Each participant attends a single session comprising a 40-shot pre-test, 20 minutes of real or sham stimulation, and a 40-shot post-test, with shots measured by a TrackMan 4 launch monitor across eight standardized club categories. The primary outcomes are change scores (post minus pre) in carry distance, ball speed, smash factor, within-player carry-distance variability, and absolute lateral deviation. Effects will be examined overall and as a function of skill level (categorical group and continuous golf handicap).
Eligibility Criteria
Inclusion Criteria:
* Age ≥ 16 years;
* at least 2 years of systematic golf training;
* own set of clubs covering the standardized test clubs;
* right-handedness;
* normal or corrected-to-normal vision;
* no musculoskeletal injury in the previous 6 months that would affect the golf swing.
Exclusion Criteria:
* History of neurological or psychiatric disease; epilepsy;
* metal implants in the head; pregnancy;
* skin lesions under the electrode sites;
* current use of central-nervous-system-active medication;
* migraine within the previous year.
Source: ClinicalTrials.gov (NCT07839910). StuddyBuddy aggregates publicly available trial information.